AHA Cardiovascular Evening Symposium

Scientific Sessions 2014 - grow your career and knowledge
 
 

AHA Cardiovascular Evening Symposium

Please join us for the AHA Cardiovascular Evening Symposium that are planned by the AHA’s Committee on Scientific Sessions Program. 
The AHA Cardiovascular Evening Symposium is a continuing education activity.

Saturday -  Diabetes and Cardiovascular Disease: Current Controversies
Sunday - Heart Failure: Challenges Old and New
Monday - Atrial Fibrillation Management: Clinical Challenges

 
Saturday Banner
Diabetes and Cardiovascular Disease: Current Controversies
Date: Saturday, Nov. 16, 2013

Time:
7–9 p.m.
Please note registration will begin at 6:00 p.m. (first come first serve basis) followed by a modest dinner.
Location:Omni Dallas Hotel
Dallas Ballroom BC
555 South Lamar Street
Dallas, TX 75202
214.744.6664
Overview:The session comprises of 5 speakers, each with a 24-minute lecture.
Target Audience:Cardiologists, cardiology interventionalists, primary care physicians, nurses and nurse practitioners, diabetes educators, pharmacists, endocrinologists, other cardiovascular specialists.
Learning Objectives:  

1. Identify the most appropriate hyperglycemic agent(s) for a variety of patient types based on the drug’s safety, efficacy, tolerability, and potential effects on cardiovascular health.

2. List the causes and effects of noncompliance with sglycemic control agents and describe opportunities to improve adherence in their patients.

3. Discuss the relevance of current evidence in guiding treatment selection for patients with diabetes and multivessel CAD.

4. Describe the most appropriate approach—medical therapy, PCI, or surgery—to manage stable coronary artery disease in individual patients with diabetes.
 


Downloadable Agenda and Faculty Itinerary

Saturday's Symposium is supported by an educational grant from:
Merck Logo - Grantors page


Sunday Banner
Heart Failure: Challenges Old and New
Date: Sunday, Nov. 17, 2013 
Time:7–9 p.m.
Please note registration will begin at 6:00 p.m. (first come first serve basis) followed by a modest dinner.
Location:Omni Dallas Hotel
Dallas Ballroom BC
555 South Lamar Street
Dallas, TX 75202
214.744.6664
Overview:The session comprises of 3 case presentations with 6 speakers, each with 15-minute lectures and 5-minute wrap-up in between cases.
Target Audience:Primary care physicians, cardiologists, interventional cardiologists, cardiac surgeons, nurse practitioners and pharmacists.
Learning Objectives:  

1. Discuss new data emerging from the STICH trial and the clinical implications of these findings.

2. Describe the aims of the STICHES trial and their potential implications for clinical practice.

3. Discuss evidence-based and consensus opinion regarding the management of decompensated heart failure, focusing on the CARRESS and DOSE trials

4. Discuss new guidelines and data on heart failure devices, including their implications for patient selection and clinical practice.

5. Discuss evidence-based and consensus opinion regarding the most appropriate management of CHD in a pediatric population and the implications for current practice.

6. Discuss evidence-based and consensus opinion regarding the appropriate use of noninvasive imaging in the diagnosis and management of HF.
 


Downloadable Agenda and Faculty Itinerary

Sunday's Symposium is supported by an educational grant from: 
  Amgen LogoNovartis Grantor Logo


Monday Banner
Atrial Fibrillation Management: Clinical Challenges
Date: Monday, Nov. 18, 2013
 
Time:7–9 p.m.
Please note registration will begin at 6:00 p.m. (first come first serve basis) followed by a modest dinner. 
Location:Omni Dallas Hotel
Dallas Ballroom BC
555 South Lamar Street
Dallas, TX 75202
214.744.6664
Overview:The moderator will present and discuss a preplanned case. The case will represent a patient with mildly symptomatic PAF with a CHADS2 score of 1 to perhaps 2. The type of case represents how a patient is managed differently by various physicians. Three questions will be posed to the learners: (1) Whether and what type of anticoagulation should be used, (2) Rate vs. rhythm, (3) Indications for ablation. An ARS poll will be conducted before each test question to determine the learner’s responses. After each poll the presenters will give their opinion.
Target Audience:Primary care physicians, cardiologists, electrophysiologists, cardiovascular surgeons, cardiovascular nurses, primary care nurse practitioners, and pharmacists.
Learning Objectives:  

1. Describe the appropriate workup for patients with suspected AF, and additional tests that may be useful in specific situations.

2. Describe the use of risk stratification tools such as CHA2DS2-VASc and HAS-BLED to determine which patients should receive anticoagulation.

3. Identify the most appropriate oral anticoagulant based on individual patient characteristics.

4. Identify the most appropriate patients for rate or rhythm control.

Downloadable Agenda and Faculty Itinerary

Monday's Symposium is supported by an educational grant from:
BMS Logo ES SponsorPfizer Logo ES SponsorTeam A Logo

Become A Member

Become a professional member of the American Heart Association/American Stroke Association.

Join or renew your AHA/ASA Professional Membership
to qualify for members-only awards, and:

• Affiliate with one of 16 Scientific Councils.
• Save on AHA/ASA Scientific Sessions.
• Save on print publications.
• Apply for research funding and not pay a fee
• Enjoy many more membership benefits.

Promo code: WDJ008ZZ